Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Akaike (Kumamoto, Japan), K. Saruwatari (Kumamoto, Japan), S. Oda (Kumamoto, Japan), S. Hamada (Kumamoto, Japan), Y. Tomita (Kumamoto, Japan), S. Saeki (Kumamoto, Japan), H. Ichiyasu (Kumamoto, Japan), K. Fujii (Kumamoto, Japan), S. Shiraishi (Kumamoto, Japan), T. Sakagami (Kumamoto, Japan). Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease. 1313

Member's Comments

No comment yet.

Related content which might interest you: CT and interstitial lung disease Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Nitrofurantoin-induced interstitial lung disease Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 The utility of 18F-FDG PET/CT in chronic sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020 Year: 2020 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020 Year: 2020